Skip to main content
Premium Trial:

Request an Annual Quote

Bruker AXS Inks X-Ray Optics JV With GKSS Spinoff

NEW YORK, Feb. 1 - Bruker AXS and Incoatec have created a joint venture to research, develop, and produce X-ray optics, Bruker said on Friday.

 

Under the terms of the JV, Bruker will hold a 51 percent stake in Incoatec, a spinoff of GKSS, a materials research center based in Germany. GKSS will license its relevant patents to Incoatec.
 
Bruker AXS will exclusively market the Incoatec products worldwide, and will provide capital and R&D resources "to optimize the use of these optics in the field of X-ray instrumentation," Bruker, of Madison, Wis., said in a statement. 

 

Financial details of the JV were not disclosed. 

 

The deal "further enhances our already broad in-house technology portfolio, and allows us to drive development of next-generation optics technologies for our life science and materials science systems," said Martin Haase, president and CEO of Bruker AXS.


"We are very pleased to see our long-standing R&D collaboration [with GKSS] now result in the commercialization of high-intensity X-ray optics which will improve the performance of our products even further," said Haase.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.